Average Ratings 1 Rating
Average Ratings 0 Ratings
Description
Claude Mythos 5 is a frontier AI model from Anthropic created for highly trusted users working on advanced cybersecurity, infrastructure protection, and scientific research. It is based on the same core model as Claude Fable 5, but certain safeguards are lifted for approved partners operating under restricted access programs. The model offers exceptional performance across software engineering, cybersecurity analysis, autonomous development workflows, scientific reasoning, visual understanding, and long-context tasks. In cybersecurity, Claude Mythos 5 is positioned for cyberdefenders and critical infrastructure providers who need advanced AI support for securing complex systems. In life sciences, the model has demonstrated strong capabilities in drug design, protein research, molecular biology, and genomics. Claude Mythos 5 can perform long-running research and technical workflows with minimal high-level human input. Anthropic designed the model for controlled deployment because its advanced capabilities could create misuse risks if broadly available without safeguards. Access is initially limited to Project Glasswing partners, with broader trusted access programs planned for cybersecurity and select biology researchers. Claude Mythos 5 helps approved organizations apply powerful AI to high-impact technical and scientific challenges while operating within a stricter governance model.
Description
Profluent's innovative platform transforms the field of protein design by seamlessly combining cutting-edge AI technology with its own experimental capabilities, allowing for the development of proteins that are either inspired by nature or entirely newly conceived. This comprehensive methodology provides precise, flexible, and scalable solutions to intricate biological problems, resulting in advancements that push the boundaries of protein functionality. Profluent's foundational models extend protein design beyond the constraints of traditional random approaches, enabling the simultaneous optimization of various characteristics, enhancing sequence diversity, and unlocking new functionalities. By venturing into unexplored protein territories, Profluent presents distinctive opportunities that surpass the limitations of natural or patented proteins, streamlining the process for partners to achieve commercial viability in a more cost-effective and accessible manner. Underpinning Profluent's capabilities is a strong dedication to scientific excellence, utilizing a wide range of datasets and advanced AI techniques to address complex challenges effectively. As a result, Profluent not only advances protein engineering but also sets a new standard in the industry, fostering innovative collaborations and breakthroughs.
API Access
Has API
API Access
Has API
Integrations
Bash
Bind AI
Brokk
C
C++
Cherry Studio
Dessix
Devin Desktop
Go
HTML
Integrations
Bash
Bind AI
Brokk
C
C++
Cherry Studio
Dessix
Devin Desktop
Go
HTML
Pricing Details
$10 per 1 million (input)
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Anthropic
Founded
2023
Country
United States
Website
claude.ai
Vendor Details
Company Name
Profluent
Founded
2022
Country
United States
Website
www.profluent.bio/platform
Product Features
Product Features
Artificial Intelligence
Chatbot
For Healthcare
For Sales
For eCommerce
Image Recognition
Machine Learning
Multi-Language
Natural Language Processing
Predictive Analytics
Process/Workflow Automation
Rules-Based Automation
Virtual Personal Assistant (VPA)